14-day Premium Trial Subscription Try For FreeTry Free
$0.0040
-0.0007 (-15.74%)
At Close: May 08, 2024
Forecast Fundamentals Insider Trading Signals Historical Prices Predictions News Profile
There is currently no insider trading information for this ticker.

However, we invite you to learn more about this term and how to use this knowledge to benefit your trading strategy:
Click to get the best stock tips daily for free!

About Enzolytics Inc

Enzolytics Enzolytics, Inc., a drug development company, focuses to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases. Its patented anti-HIV therapeutics and a proprietary methodology for producing human IgG1 monoclonal antibodies for treating infectious diseases with non-toxic passive immunotherapy. The company has clinically tested anti-HIV therapeutics. In addition, it has created a proprietary cell l... ENZC Profile

Golden Star

Ticker Date Change Price
VCSH May 03 0.0130% $76.93
BNDX May 03 0.349% $48.68
BBCA May 03 1.26% $65.44
ISTB May 03 0.0425% $47.11
ADTH May 03 5.56% $3.24
WMT May 03 1.34% $59.82
UNP May 03 0.84% $240.36
INGR May 03 1.75% $114.56
ASH May 03 2.26% $95.85
WU May 03 0.449% $13.37
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT